Are OPCH, PTC, RXO Obtaining Fair Deals for their Shareholders?
Halper Sadeh LLC, an investor rights law firm, announced it is investigating Option Care Health, PTC and RXO for potential securities-law violations and fiduciary breaches related to their pending take-private/sale transactions. For OPCH, the firm is probing the proposed sale to CD&R and McKesson at $32.05 per share, and may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.
Key figures
- Ptc deal price per share
- 205
- Rxo deal price per share
- 17.25
- Rxo stock exchange ratio
- 0.0856
- Opch deal price per share
- 32.05
- Rxo combined company ownership pct
- 11%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.